240 related articles for article (PubMed ID: 6779776)
21. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
[TBL] [Abstract][Full Text] [Related]
22. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.
Krieg DP; Helmke RJ; German VF; Mangos JA
Infect Immun; 1988 Dec; 56(12):3173-9. PubMed ID: 3141284
[TBL] [Abstract][Full Text] [Related]
23. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil function in gram-negative rod bacteremia. The interaction between phagocytic cells, infecting organisms, and humoral factors.
Weinstein RJ; Young LS
J Clin Invest; 1976 Jul; 58(1):190-9. PubMed ID: 819460
[TBL] [Abstract][Full Text] [Related]
25. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
[No Abstract] [Full Text] [Related]
26. Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes.
Vitkauskiene A; Scheuss S; Sakalauskas R; Dudzevicius V; Sahly H
Infection; 2005 Oct; 33(5-6):356-61. PubMed ID: 16258867
[TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains.
Pier GB; Boyer D; Preston M; Coleman FT; Llosa N; Mueschenborn-Koglin S; Theilacker C; Goldenberg H; Uchin J; Priebe GP; Grout M; Posner M; Cavacini L
J Immunol; 2004 Nov; 173(9):5671-8. PubMed ID: 15494518
[TBL] [Abstract][Full Text] [Related]
28. Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide.
Bufler P; Schmidt B; Schikor D; Bauernfeind A; Crouch EC; Griese M
Am J Respir Cell Mol Biol; 2003 Feb; 28(2):249-56. PubMed ID: 12540493
[TBL] [Abstract][Full Text] [Related]
29. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
[TBL] [Abstract][Full Text] [Related]
30. Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes.
Roe EA; Jones RJ
Br J Exp Pathol; 1974 Aug; 55(4):336-43. PubMed ID: 4215443
[TBL] [Abstract][Full Text] [Related]
31. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
33. Selection of nonmucoid derivatives of mucoid Pseudomonas aeruginosa is strongly influenced by the level of iron in the culture medium.
Boyce JR; Miller RV
Infect Immun; 1982 Aug; 37(2):695-701. PubMed ID: 6811438
[TBL] [Abstract][Full Text] [Related]
34. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
35. The invasion of burned skin by Pseudomonas aeruginosa.
Carney SA; Dyster RE; Jones RJ
Br J Dermatol; 1973 Jun; 88(6):539-45. PubMed ID: 4197888
[No Abstract] [Full Text] [Related]
36. Granulocyte function and Pseudomonas burn wound infection.
McEuen DD; Gerber GC; Blair P; Eurenius K
Infect Immun; 1976 Aug; 14(2):399-402. PubMed ID: 823111
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic multiplex polymerase chain reaction assay for the identification of Pseudomonas aeruginosa from the skin biopsy specimens in burn wound infections and detection of antibiotic susceptibility.
Mashouf RY; Zamani A; Farahani HS
Saudi Med J; 2008 Aug; 29(8):1109-14. PubMed ID: 18690301
[TBL] [Abstract][Full Text] [Related]
38. [Pseudomonas aeruginosa infections in burns].
Nasilowski W; Bukowska D; Serafińska D; Zietkiewicz W
Pol Tyg Lek; 1975 May; 30(20):845-8. PubMed ID: 806062
[No Abstract] [Full Text] [Related]
39. Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients.
Speert DP; Eftekhar F; Puterman ML
Infect Immun; 1984 Mar; 43(3):1006-11. PubMed ID: 6421734
[TBL] [Abstract][Full Text] [Related]
40. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
Speert DP; Wong SY; Macdonald M; Sargeant R
Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
